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Purpose. The objective of this study was to evaluate key motif re-
quirements of human calcitonin (hCT)-derived peptides for the per-
meation through the plasma membrane of MDCK monolayers, as
epithelial model.
Methods. Truncated and sequence-modified fluorescent-labeled
hCT-derived peptides were synthesized through Fmoc chemistry.
Peptide uptake by confluent MDCK was observed by confocal laser
scanning microscopy. The cytotoxic effect of the peptides on cellular
integrity was followed by LDH release. For direct comparison we
covered the cellular uptake of established cell penetrating peptides,
Tat(47-57) and penetratin(43-58).
Results. Truncated sequences of hCT, from hCT(9-32) to hCT(18-
32), penetrated the plasma membrane and demonstrated a sectoral,
punctuated cytoplasmic distribution. The uptake process appeared to
be temperature-, time- and concentration-dependent. Amino acid
modifications of hCT(18-32) indicated that both the proline in posi-
tion 23 and the positive charge of lysine in position 18 are crucial for
peptide uptake. The reverse sequence hCT(32-18) did not penetrate
the membrane, indicating the importance of sequence orientation.
Tat(47-57) and penetratin(43-58) showed a similar punctuated cyto-
plasmic distribution in MDCK and HeLa cell lines. No relevant tox-
icity was observed.
Conclusions. Selected hCT-derived peptides have cell penetrating
properties. The uptake mechanism seems to involve an endocytic
pathway.
KEY WORDS: human calcitonin; cell penetrating peptides; cell
uptake; endocytosis; MDCK.
INTRODUCTION
The therapeutic potential of peptide-, protein-, and
nucleic acid-based drugs is frequently compromised by their
limited ability to cross the plasma membrane resulting in poor
cellular access (1,2). Conjugation of such therapeutic agents
to cell penetrating peptides (CPPs) has been suggested to
improve their bioavailability. Several examples of CPPs have
been described so far, such as 1) HIV-1 Tat-derived peptides
(3–5), 2) the third helix of the homeodomain of Antennape-
dia, i.e., penetratin [e.g. Antp(43-58)] (6,3) the herpes simplex
virus VP22 protein (7,8,4) polyarginines (9,10). CPPs have
been shown to cross cellular membranes and to deliver con-
jugated (or fused) biopharmaceuticals, such as peptide
nucleic acids (PNAs) (11), antisense oligonucleotides (12),
full-length proteins (4,13), or nanoparticles (14) and lipo-
somes (15) into cells. The exact mechanisms underlying the
translocation of CPP across the cellular membrane is still
poorly understood. However, several similarities in translo-
cation mechanism were found: the internalization of these
peptides was neither significantly inhibited by low tempera-
ture, depletion of cellular ATP pool, nor inhibitors of endo-
cytosis (3,6,10,16). Therefore, translocation was concluded to
result from a direct transfer through the lipid bilayer of the
cell membranes (3,6). Recently, however, the mechanisms of
protein/peptide translocation have been re-evaluated and the
involvement of endocytosis in cellular internalization of both
CPPs and CPPs conjugated to PNAs has been suggested
(17,18).
In the present study, we report on a new group of peptide
sequences derived from the C-terminal domain of human cal-
citonin (hCT) with ability to translocate the plasma mem-
brane of Madin–Darby canine kidney cell line (MDCK)
monolayers, a meaningful cellular model for columnar-type
epithelia (19,20). Our hCT-derived CPP carry a relatively low
positive charge in contrast to other CPPs, which are highly
positively charged (arginine- or lysine-rich) at physiologic pH
(3,10,21). A previous study demonstrated that the C-terminal
fragment of hCT featuring residues 9 to 32, that is, hCT(9-32),
as well as human calcitonin itself are internalized in vitro into
bovine nasal epithelium (22). Moreover, we previously
showed that the green fluorescent protein conjugate GFP-
hCT(9-32) was also translocated into bovine nasal epithelium
(23). To further investigate the underlying principles of pep-
tide uptake we analyzed, by confocal laser scanning micros-
copy (CLSM), key sequence requirements for translocation
by generating a series of peptides by both truncations and
sequence variations of hCT(9-32). The present work reveals
that the minimally required hCT sequence that could be in-
ternalized in MDCK was hCT(18-32). For reference, the in-
vestigated hCT peptides were compared with Tat(47-57) and
penetratin(43-58) using cellular uptake assays in both MDCK
and HeLa cells. Once translocated into the cells all the tested
peptides demonstrated a punctuated cytoplasmic distribution,
suggesting the involvement of endocytosis.
MATERIALS AND METHODS
Materials
MDCK (low resistance, type II) was a gift from the Bio-
pharmacy group, ETH (Zurich, Switzerland; Ref. 20). Cervi-
cal carcinoma cells, HeLa, were obtained from American
Type Culture Collection (Rockville, MD, USA). Cell culture
media, L-glutamine, penicillin, streptomycin, and phosphate-
buffered saline without calcium and magnesium were from
Invitrogen Corporation (Carlsbard, CA, USA). Fetal calf se-
rum (FCS) was purchased from Winiger AG (Wohlen, Swit-
zerland) and 5(6)-carboxyfluorescein from Fluka (Buchs,
Switzerland). Hoechst 33342, LIVE/DEAD Viability/Cyto-
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toxicity kit assay and 5(6)-carboxytetramethylrhodamin
(TAMRA) were purchased from Molecular Probes (Eugene,
OR, USA). Human calcitonin (hCT) was a gift from H. Rink
from Novartis (Basel, Switzerland). Human calcitonin gene-
related peptide (hCGRP) and human amylin (hAmylin) were
purchased from Bachem (Bubendorf, Switzerland), and hu-
man adrenomedullin (hADM) from Peptide Institute in
Osaka, Japan. Forskolin was from CalbioChem (San Diego,
CA, USA). Tetramethyl rhodamine isothiocyanate (TRITC)
dextran, lactate dehydrogenase (LDH) kits, and all other
chemicals were commercially available. Cell culture inserts
(polyethylene terephthalate, 4.2-cm2 growth area, 0.4-m
pore size, 1.6 × 106 pores/cm2) and companion plates were
purchased from Falcon (Franklin Lakes, NJ, USA). Glass
chamber slides were obtained from Nunc (Roskilde, Den-
mark). Twelve- and 24-well plates were obtained from TPP
(Trasadingen, Switzerland). The used UV spectrophotometer
was a Varian Cary 50. The transepithelial electrical resistance
of cell monolayers grown on inserts was measured using the
Millicell-ERS system from Millipore (Billerica, MA, USA).
Methods
Synthesis of hCT Fragments, Labeling, and Identification
Linear hCT fragments were synthesized according to
Rist et al. (24) using Rink amide resin to obtain C-terminal
amides. All fragments were labeled at the N-terminus with
5(6)-carboxyfluorescein or with TAMRA, whereas the pep-
tide was still bound to the resin with fully protected side
chains (25). Coupling was performed using an 8-fold excess of
TAMRA or a 10-fold excess of 5(6)-carboxyfluorescein, dii-
sopropylcarbodiimide, and 1-hydroxybenzotriazole. The
overall coupling time was 30 min for 5(6)-carboxyfluorescein
and 45 min for TAMRA. The 5(6)-carboxyfluorescein labeled
peptides were cleaved with TFA/thioanisole/thiocresol (90:5:
5, v/v/v) within 3 h at room temperature, precipitated from
cold diethyl ether, and collected by centrifugation. The crude
peptides were dissolved in methanol/piperidine (9:1, v/v) and
shaken for 1 h to remove excess of carboxyfluorescein. For
TAMRA-labeled peptide, the excess dye was removed by
extensive washing with N,N-dimethylformamide, dichloro-
methane, ethanol and diethylether, whereas the peptide was
still attached to the resin. The TAMRA-labeled peptide was
then cleaved and precipitated from cold diethyl ether and
collected by centrifugation. All the peptides were subse-
quently lyophilized.
The following sequences were synthesized (Table I). N-
terminally truncated fragments: Starting from the C-terminal
fragment hCT(9-32), we synthesized further peptides with
various truncations, down to a total length of 9 amino acids,
hCT(24-32). C-terminally truncated fragment: hCT(18-31).
Amino acid replacements: Single amino acid replacements
were performed in position 17, 18, 19, and 23 (see Table I for
details). Extended sequences: For elongation of the C-termin-
al segment, we added two alanines to the C-terminus of
hCT(18-32). Reverse sequence: hCT(32-18), the reverse
amino acid sequence of hCT(18-32). Random sequence: A
peptide sequence containing the 24 amino acids of hCT(9-32)
in a random position was synthesized as a negative control.
Peptides were purified by preparative high-performance
liquid chromatography (HPLC) and their purity confirmed by
HPLC analysis using a LiChrospher 100 RP-18 column with a
flow rate of 1 ml/min using an acetonitrile:water (containing
0.1% TFA) gradient. Fluorescence was detected at 517 nm
and UV at 220 nm. The molecular weight was verified by mass
spectrometry (Finnigan Mat SSQ 710/ Waters 600-MS).
Synthesis of Tat(47-57) and Penetratin(43-58), Labeling,
and Identification
Synthesis of Tat(47-57) and penetratin(43-58) (see Table
I) were conducted by solid phase on an Applied Biosystems
433A peptide synthesizer following the Fmoc chemistry pro-
tocol. Two glycines were added, one at the N-terminal and
one at the C-terminal end of the Tat(47-57) peptide to pro-
vide links for fluorochrome binding. In the case of penetra-
tin(43-58), the C-terminal end was amidated to improve its
stability. The peptides were labeled at the N-terminus with a
3-fold excess of 5(6)-carboxyfluorescein while still bound to
the resin with fully protected side chains. The overall coupling
time was 3 h followed by washing steps with N,N-dimethyl-
formamide. The peptides were cleaved with TFA/water/tri-
isopropylsilane/ethandithiol (92.5:2.5:2.5:2.5, v/v/v/v) within 2
h at room temperature, precipitated from tert-butylmethyl-
ether, collected by centrifugation, and lyophilized.
Peptides were purified by preparative HPLC and their
purity confirmed by HPLC analysis using an EC 250/4
Nucleosil 300-5 C18 with a flow rate of 1 ml/min. A linear
gradient starting at 90% solvent A (water:TFA, 99.9:0.1, v/v)
and 10% solvent B (acetonitrile:TFA, 99.915:0.075, v/v) to
100% solvent B over 50 min. UV detection was set at 222 nm.
The molecular weights were verified by mass spectrometry
(Perkin-Elmer Sciex API III Quadrupol Biomolecular Mass
Analyzer).
Cell Culture
MDCK cells were grown under standard conditions in
minimum essential medium with Earl’s salts containing 10%
heat-inactivated FCS, 1% L-glutamine and 1% penicillin/
streptomycin (20). HeLa cells were cultured as exponentially
growing subconfluent monolayers on 25-cm2 culture flasks in
Dulbecco’s modified eagle medium (high glucose) supple-
mented with 10% heat-inactivated FCS and 1% penicillin/
streptomycin.
CLSM
Exponentially growing MDCK and HeLa cells were
seeded onto either four-well glass chamber slides or cells cul-
ture inserts, cultured 2 or 3 days for proliferating cells and 10
days for confluent cells. MDCK cells were seeded at a con-
stant density of 2 × 104 cells/cm2 and HeLa cells at 105 cells/
cm2. For confluent cells, medium was changed twice a week
until confluent monolayers formed. For uptake experiments,
cells were first incubated in serum free medium for 30 min.
The medium was then discarded and the cells further incu-
bated in serum-free medium containing fluorescence-labeled
peptides or unconjugated fluorophore at the appropriate con-
centration. Simultaneously, nuclei were stained with 1 g/ml
Hoechst 33342. When appropriate, endosomes were stained
with TRITC-dextran. The study was conducted at 37°C or
4°C with horizontal mechanical shaking (150 rpm). Subse-
quently, cells were rinsed three times with serum-free me-
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dium and mounted with or without fixation. Fixation was
performed at room temperature for 30 min in 3% (v/v) form-
aldehyde before being rinsed with phosphate-buffered saline.
The cells were then scanned using a Zeiss CLSM 410 inverted
microscope (20) and 3D multichannel image processing was
performed using the IMARIS software.
Endosome Staining
MDCK proliferating cells growing on four-well glass
chamber slides were incubated with 4 mg/ml TRITC-dextran
for 45 min to stain endosomes (26). Simultaneously, cells were
incubated with 40 M of hCT-derived peptide. Before CLSM
observations, cells were fixed.
LIVE/DEAD Viability/Cytotoxicity Assay
MDCK cells were incubated at 4°C for 45 min with cold
serum-free medium. Thereafter, serum-free medium was re-
moved and replaced by serum-free medium (37°C) containing
a mixture of 3 M calcein AM (green stain of cytoplasm of
enzymatically active viable cells, approx. 530 nm), and 6 M
ethidium homodimer (passage of damaged cells membranes
and subsequent red stain of nuclei, > 600 nm) and MDCK
were further incubated for 30 min at 37°C. Before CLSM
observations, cells were washed three times with serum-free
medium. To determine optimal dye concentration of ethid-
ium homodimer, cells were killed using 70% methanol for
30 min.
LDH Release
The release of LDH indicates compromised cell mem-
brane integrity. MDCK monolayers were grown on 12-well
plates and incubated with carboxyfluorescein-labeled pep-
tides at various concentrations and times of incubation. LDH
release was estimated by withdrawing a 40-l sample from
each well and transferring it to 1 ml phosphate buffer (50 mM,
pH 7.5) containing nicotinamide adenine dinucleotide (0.18
mM) and pyruvate (0.6 mM). The change in absorbance was
measured at 340 nm using an UV spectrophotometer. Triton-
X100 was used as positive control.
Investigation of hCT Receptor Expression on MDCK Cells
by Measurement of cAMP Accumulation
MDCK cells were seeded onto 24-well plates at a density
of 40,000 cells/well. Three days later the medium was replaced
with a medium containing 136 mM NaCl, 5.4 mM KCl, 1 mM
Na2HPO4, 5.5 mM glucose, 1 mM CaCl2, 1 mM MgCl2, 1 mM
isobutylmethylxanthine, 0.1% bovine serum albumin, and 20
mM HEPES, pH 7.45. Incubation with test substances was
performed at 37°C in a final volume of 200 l for 15 min.
Thereafter, the medium was replaced by 500 l of ice-cold
95% ethanol containing 1 mM HCl, and cAMP was extracted
at 4°C for 1 h. Ethanol was evaporated in a SpeedVac con-
centrator (Savant) and cAMP determined in reconstituted
extracts by radioimmunoassay (RIA) as described by Moran
et al. (27).
RESULTS
Cellular Uptake of hCT-Derived Peptides in MDCK Cell
Monolayers and Tat(47-57) and Penetratin(43-58) in both
MDCK and HeLa Cells
The distributions of carboxyfluorescein and carboxyfluo-
rescein-labeled hCT-derived peptides were followed in living,
nonfixed MDCK cell monolayers grown either on cell culture
inserts (transepithelial electrical resistance 111 ± 21 ·cm2,
n  68) or glass chamber slides. The localization of Tat(47-
57) and penetratin(43-58) within fixed or nonfixed MDCK
cell monolayers and HeLa grown on glass chamber slides was
also determined. No intracellular fluorescence was observed
when the cells were incubated for 45 min with the negative
controls, that is, no peptide (Fig. 1A), 40 M nonconjugated
carboxyfluorescein (Fig. 1B), or 40 M random sequence
(Fig. 1C). The latter, however, showed an extracellular fluo-
rescence pattern. When incubated for 45 min at 37°C with
MDCK cell monolayers the intracellular hCT-derived pep-
tides (40 M) demonstrated a punctuated cytoplasmic distri-
bution (Figs. 1D and 1E). The translocation efficiency of pep-
tides visually decreased in the order of hCT(9-32) ≈ hCT(12-
32) > hCT(15-32) > hCT(18-32) (Table I). Although even the
shortest fragment hCT(18-32) displayed some degree of
translocation, the longest fragments such as hCT(9-32) and
hCT(12-32) demonstrated visually a higher degree of uptake,
as assessed by the apparent fluorescence intensity of the
CLSM micrographs. All internalized fragments demonstrated
a sectoral distribution, as intracellular fluorescence was ob-
served only in some regions of the monolayers and not ho-
mogeneously distributed across the cell layers (Figs. 1F and
1G). Other than fluorescence no other visually detectable
differences between the cell regions with and without trans-
location were observed. When assayed at 4°C the hCT-de-
rived peptides were not translocated into the cells. The fully
preserved viability of the cells at 4°C was assessed with the
LIVE/DEAD Viability/Cytotoxicity Assay Kit (data not
shown).
To elucidate the underlying principles of the cellular up-
take, the amino acid sequence of hCT(18-32) was modified as
follows (for details, see Table I). When lysine in position 18
was replaced by another basic residue, such as arginine, the
capacity for translocation was conserved. Nevertheless, re-
placement by a non-charged amino acid, for example, alanine,
or by a D-lysine abolished the uptake. Abolition of the up-
take was also observed when exchanging the proline 23 with
a more flexible residue, such as alanine. The extension of the
sequence hCT(18-32) by coupling a phenylalanine to the N-
terminus [N17F-hCT(17-32)], did not affect the capacity for
translocation. On the other hand, when coupling a cysteine
[N17C-hCT(17-32)] or a lysine [N17K-hCT(17-32)] to the N-
terminus and two alanines to the C-terminus [A33A34-hCT(18-
34)] translocation of the peptides was abolished. The impor-
tance of the orientation for peptide internalization was
demonstrated since the reverse analog hCT(32-18) was not
internalized. The role of the proline at the C-terminus seemed
not to be crucial since hCT(18-31) could permeate the plasma
membrane. However, the peptide hCT(9-29) was not inter-
nalized in MDCK cells, suggesting that the C-terminal do-
main is essential for cellular uptake.
The metabolic breakdown of hCT in contact with cells
was previously found to initiate in the mid section of the
peptide, that is, close to the N-terminus of hCT(18-32), pre-
dominantly through chymotryptic and tryptic-like cleavage
(28). Therefore, it was believed that replacement of L- by
D-amino acid residues in the hCT fragments would enhance
their metabolic stability. The impact of such amino acid modi-
fications upon membrane translocation was also investigated.
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Exchange of L-phenylalanine in position 19 and L-lysine in
position 18 by their D-enantiomers abolished the membrane
translocating capacity of the peptides. Confocal microscopy
pictures were identical to the negative controls as shown in
Figs. 1A and 1B. The hCT(9-32) and hCT(12-32) fragments
demonstrated similar punctuated cytoplasmic distributions
whether the cells were grown on cell culture inserts or on
glass chamber slides, providing evidence that the culture sup-
port had no influence on peptide uptake. Moreover, fixation
of the cells before CLSM did not affect the pattern of inter-
nalization, except for a somewhat brighter fluorescence in
fixed vs. nonfixed cells. Consequently, artifacts by fixation
could be excluded. The fluorophore did not significantly alter
peptide uptake, since hCT(9-32) fragments labeled either
with carboxyfluorescein or TAMRA did not modify the cel-
lular pattern with MDCK monolayers. These findings further
support the results of Lang et al., who demonstrated that the
conjugation of fluorescein isothiocyanate (FITC) to hCT had
no significant influence upon the transfer of peptides across
excised nasal mucosa (29).
Concentration Effects of hCT-Derived Peptide upon Uptake
into MDCK Cell Monolayers
To assess the effect of peptide concentration and to
check for any saturation of the translocation, hCT(9-32),
hCT(12-32) and hCT(18-32) were incubated with MDCK
cells for 45 min at 10, 20, 40, and 100 M. For CLSM inspec-
tion, cells remained nonfixed. Below the concentration of 40
M only weak intracellular fluorescence was observed. At a
concentration of 40 M, detection was at optimum. At a pep-
tide concentration of 100 M, the intracellular fluorescence
did not increase, instead accumulation of apical fluorescence,
presumably fluorescent aggregates of the peptides, was de-
tected on the cell layers (Fig. 1H). A similar aggregation pat-
tern was also observed at 100 M with hCT-derived peptides
devoid of translocating abilities.
Effect of Incubation Time upon Uptake of hCT-Derived
Peptides in MDCK Cell Monolayers
hCT(9-32), hCT(12-32), and hCT(18-32) were also incu-
bated at 40 M for four different times intervals: 15, 30, 45,
and 60 min on MDCK cell monolayers. Negligible or poor
internalization was observed at either 15 or 30 min. However,
incubations for more than 30 min were sufficient for the ve-
sicular internalization of peptides (data not shown).
Cellular Uptake of hCT-Derived Peptides in Proliferating
MDCK Cells
The distribution of hCT(9-32), hCT(18-32), hCT (21–32),
and random sequence (40 M) was also investigated in pro-
liferating MDCK cells after a 45-min incubation. For CLSM
inspection cells were fixed. All fragments demonstrated a
punctuated cytoplasmic distribution, clearly above the nega-
tive controls, that is, serum-free medium and fluorophore,
respectively. The punctuated cytoplasmic distribution of
hCT(18-32) is illustrated in Fig. 1 (data not shown for hCT(9-
32), hCT(21-32), and random sequence). When hCT(9-32)
was concomitantly incubated with TRITC-dextran (Fig. 1J), it
was found to predominantly co-localize with TRITC-dextran
(Fig. 1K), as indicated by the resulting yellow coloration (Fig.
1L), demonstrating the endocytotic nature of the cellular up-
take of hCT-derived peptides. At the same time, the discrete
observation of green and red vesicles indicated independent
uptake of the peptide and the fluid phase endocytic marker
(Fig. 1L). No uptake of TRITC-dextran was observed in con-
fluent MDCK cells.
Cellular Uptake of Tat(47-57) and Penetratin(43-58) in
MDCK Cell Monolayers and HeLa Cells
The highly positively charged carrier peptides Tat(47-57)
and penetratin(43-58) were also incubated with MDCK
monolayers for 1 h with a concentration of 10 M. Tat(47-57)
demonstrated a cytoplasmic and punctuated pattern in fixed
cells. Although analogous to that observed with the hCT-
derived peptides, the pattern was more uniformly distributed
across the monolayers with Tat(47-57) (Figs. 2A and 2B).
With penetratin(43-58), however, concomitant staining of the
surface of the plasma membrane and intracellular transloca-
tion was observed (Figs. 2C and 2D). When using nonfixed
MDCK cell monolayers, the intracellular patterns of the two
cationic CPP were weaker but still punctuated and cytoplas-
mic. In living nonfixed and fixed HeLa cells, Tat(47-57) and
penetratin(43-58) (10 M) were mainly located in the cyto-
plasm with a punctuated distribution after 1 h of incubation
(Figs. 2E and 2F).
Cytotoxicity of hCT(9-32), hCT(18-32), hCT(21-32),
Tat(47-57), and Penetratin(43-58) on MDCK
Cell Monolayers
hCT-derived peptides were incubated at 40 M for three
different incubation times: 30, 60, and 120 min (n  4; Fig.
3A). Tat(47-57) and penetratin(43-58) peptides were incu-
bated at a concentration of 10 M during 60, 120, 180, and
240 min (n  4; Fig. 3B). Triton X-100 (0.1% in serum-free
medium) was used as positive control and serum-free medium
as negative one. The results are represented as percentage of
LDH release. The percentages were calculated by direct com-
parison to the positive control, that is, when the cell mem-
branes were permeabilized by Triton X-100. The LDH re-
lease of the positive control was taken as 100%. As depicted
in Figs. 3A and 3B, no significant differences in the percent-
age of LDH release were measured when the cells were in-
cubated with serum-free medium alone or with peptide solu-
tions. Therefore, none of the peptides tested in this study
showed a relevant toxic effect on the MDCK cell monolayers,
even after 4 h of incubation with Tat(47-57) and penetra-
tin(43-58), at the indicated concentrations.
Assessment of hCT Receptor Expression on MDCK Cells
hCT, hCGRP, hADM, and hAmylin belong to a family
of structurally and functionally related peptides that recog-
nize their respective receptors with affinity in the nanomolar
range (30), resulting in accumulation of cAMP. However,
cross-reactivity of a given receptor with other peptides of the
family is observed at high concentrations (micromolar range).
We incubated MDCK cells with hCT, hCGRP, hADM, and
hAmylin to verify whether the cells possess any calcitonin
receptor activity and, if any, cross-reactivity was present. For-
skolin, which stimulates adenylate cyclase, was used as a posi-
tive control to verify the capacity to produce cAMP. No sig-
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Fig. 1. (Legend on facing page.)
Fig. 2. (Legend on facing page.)
Tréhin et al.38
nificant accumulation of cAMP in response to hCT, hCGRP,
hADM and hAmylin, was monitored (Fig. 4), cAMP levels
remained in the range of untreated controls (2–7 pmol/well).
MDCK appeared not to possess any calcitonin or calcitonin
related receptor activity, thus suggesting that hCT-derived
peptides use an alternative mechanism to translocate into
MDCK.
DISCUSSION
Numerous peptide sequences derived from proteins with
membrane translocating properties were previously investi-
gated for their capacity as carrier peptides for the transfer of
various cargoes into the cytosol of a variety of cells (4,5,31).
Many of these CPP are highly positively charged and strongly
interact with the negatively charged extracellular matrix of
the plasma membrane (3,32). In the present study, we inves-
tigated the cell-penetrating capacities of peptides carrying
relatively modest net positive charges or being neutral,
namely C-terminal fragments of hCT, into a columnar-type
epithelium, the MDCK monolayer using CLSM. hCT (9-32)
was previously shown to translocate the plasma membrane of
excised bovine nasal mucosa (22), and to act as a transfer
vehicle for GFP into this tissue model (23). Prerequisite for
assessing the capability of hCT-derived peptides to pass the
plasma membrane of MDCK is direct detection and sufficient
resolution by CLSM. However, several aspects need to be
considered to interpret such observations. In principle, the
observed intracellular fluorescence may be emitted by either
intact peptides or metabolites still carrying the fluorophore.
For this study, we synthesized 20 different C-terminal
sequences derived from hCT (see Table I). Seven of them
translocated the plasma membrane of confluent MDCK
monolayers. The shortest internalized hCT-derived peptide
sequence was hCT(18-32). Shorter sequences lacked relevant
translocating capacity, whereas longer fragments in fact per-
meated the cell membrane. The efficiency of translocation
visually decreased in the order of hCT(9-32) ≈ hCT(12-32) >
hCT(15-32) > hCT(18-32). We also looked at the important
structural features required for internalization by modifica-
tions of the original amino acid sequence. Among these, we
tried to increase the helicity of the peptide sequence in re-
placing the proline 23 by an alanine. This modification in fact
abolished the internalization of the peptide and highlights the
importance of the proline in this position. Among other rea-
sons, the rigidity induced by the proline could be crucial for
efficient peptide internalization. By replacing the lysine in
position 18, we addressed the involvement of ionic interac-
tions and the contribution of the positive charge on mem-
brane translocation. The impact of a single positive net charge
is expected to be much inferior to that of multiple positive
charges as typically found in polycationic carrier peptides, for
example, Tat(47-57). Polycationic CPPs have been previously
reported to strongly interact with the extracellular matrix of
plasma membranes (6,33). Nevertheless, there could be a con-
tribution of the positive charge of the lysine in position 18 in
anchoring the sequences at the bilayer surface. Replacement
of lysine by noncharged alanine prevented peptide internal-
ization, whereas maintaining the positive charge by replacing
the lysine with an arginine maintained peptide internaliza-
tion. However, the conformation of the positive charge at this
position seemed to play a crucial role, since the replacement
of L-lysine by D-lysine strikingly abolished uptake. Another
role of the lysine in position 18 might be the inhibition of
premature aggregation through charge repulsion. If not sta-
bilized by a minimum positive charge hydrophobic interac-
tions of the C-terminal domain could prevail and lead to pre-
mature aggregation, that is, inactivation of shorter hCT frag-
ments than hCT(18-32). Nevertheless, this would not explain
the failure of D-lysine replacement.
Sequence extension of hCT(18-32) beyond the N- and
C-termini showed in most of the cases a loss of internalization
except when phenylalanine was added to the N-terminus.
Therefore, introduction of a peptidic spacer to serve as a cargo-
linker, should be engineered at the N-terminus, possibly by
adding a phenylalanine.
In most of the previous studies, cells incubated with poly-
cationic CPP, demonstrated rapid peptide uptake with pre-
dominant nuclear localization and lack of punctuated cyto-
plasmic labeling, which is characteristic of endocytic uptake.
Additionally, internalization of CPP was not significantly in-
hibited at low temperature, and structure-activity studies of-
ten suggested that internalization did not depend on the sec-
ondary structure, ruling out putative receptor recognition. It
<
Fig. 1. Confocal microscopy pictures of hCT derived peptides distribution in confluent MDCK monolayers and proliferating MDCK. MDCK
cells forming monolayers were incubated for 45 min at 37°C without peptide (A), with 40 M of carboxyfluorescein (B), with 40 M of the
random sequence (C), or with 40 M of carboxyfluorescein-labeled hCT(12-32) (D–G). D and E show the punctuated cytoplasmic distribution
of hCT(12-32). Intracellular vesicles are shown by arrows. E is the 3D projection of D. F and G illustrate the sectoral distribution of the
peptide. The arrowheads point to areas where the peptide is internalized. G is the 3D projection of F. H shows MDCK cells forming
monolayers incubated with 100 M of carboxyfluorescein-labeled hCT(9-32). MDCK-proliferating cells were incubated for 45 min at 37°C
with 40 M of hCT(18-32) (I) and co-incubated with 40 M of hCT(9-32) together with 4 mg/ml of TRITC-dextran for endosomal staining
(J–L). J: hCT(9-32) (green fluorescence); K: TRITC-dextran (red fluorescence); L: co-localization (yellow fluorescence) of hCT(9-32) peptide
and TRITC-dextran. The cell nuclei are shown in blue, the peptide and carboxyfluorescein in green. Processed data sets are illustrated as
xy-sections for A–D, F, H–L. a, b, d, f, and h are xz projections, and a, b, d, f, and h are yz projections. The white lines indicate
the position of the sections. Bars: 10 m. Interpretation of C needs to be restricted to areas where the optical section is on the level of the
nuclei.
Fig. 2. Cellular uptake of Tat(47-57) and penetratin(43-58) in MDCK and HeLa cells. MDCK cells forming monolayers were incubated for
1 h with 10 M carboxyfluorescein-labeled Tat(47-57) (A, B) and penetratin(43-58) (C, D). HeLa cells were incubated for 1 h with 10 M
carboxyfluorescein-labeled Tat(47-57) and penetratin(43-58), respectively (E and F). Arrows in A and B point to the punctuated cytoplasmic
distribution of Tat(47-57). Arrows in C and D show the punctuated cytoplasmic distribution of Penetratin(43-58) and arrowheads the
fluorescent peptide located on the surface of the plasma membrane. Micrographs A, C, E, and F are section micrographs (A, C, E, F: xy
section; a, c: xz projection; a, c: yz projection), whereas B and D are the respective 3D projections. The cell nuclei are shown in blue, the
peptide in green. The white lines indicate the position of the sections. Bars: 10 m.
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was thus commonly accepted that the internalization of CPPs
would not involve endocytosis or specific protein transport-
ers. Instead, passive transfer through the lipid bilayer has
been proposed as a possible mechanism of translocation
(3,6,9,10,16). Recent studies, however, contrast with this hy-
pothesis, after a punctuated cytoplasmic distribution of
Tat(48-60) and poly-arginine in HeLa and CHO cells was
observed (18). Koppelhus et al. showed that a PNA conju-
gated to C-Tat(48-60) or a modified penetratin(42-58) was
found to predominantly segregate in endocytic vesicles (17).
Both of them described an energy-dependent uptake mecha-
nism.
In the present study, we demonstrated a sectoral, punc-
tuated cytoplasmic localization of translocated hCT-derived
peptides and the absence of any nuclear fluorescence. This
latter fact may be explained by the absence of a nuclear trans-
locating motif in the sequence of the investigated peptides.
Yet, without further knowledge, explanation for the observed
sectoral distribution is still elusive. In addition, our study
suggested an energy-, time- and concentration-dependent
mechanism. However, at concentrations above 100 M the
hydrophobic C-termini of the hCT-derived peptides appear to
strongly interact and lead to the formation of aggregates as
thoroughly studied for hCT itself (34). Premature aggregation
of a peptide would efficiently prevent its internalization in a
non-concentration-dependent manner. The absence of signifi-
cant translocation of distinct modifications, particularly of
hCT(32-18), D-K18-hCT(18-32) and D-F19-hCT(18-32), vs.
translocation of others, does not exclude the involvement of a
receptor-dependent mechanism. However, owing to the dem-
onstrated absence of hCT and hCT-related receptors on
MDCK plasma membranes, the involvement of this receptor
must be excluded. Nevertheless, an alternative receptor to the
calcitonin receptor might assist in peptide internalization.
For comparison, Tat(47-57) showed a punctuated cyto-
plasmic pattern, indicating endocytic vesicles, whereas pen-
etratin(43-58) depicted both a cytoplasmic and punctuated
pattern, and an extracellular staining of the cell membrane.
However, when incubated with HeLa cells, both Tat(47-57)
and penetratin(43-58) demonstrated a similar punctuated cy-
toplasmic pattern. In MDCK and HeLa cells both peptides
demonstrated only weak nuclear uptake. Contrasting to the
present results, two independent studies recently claimed that
Tat(48-57) and Tat(44-57) cannot permeate MDCK plasma
membrane (35,36). Nevertheless, distinct differences in both
the Tat sequences, the cell culture and other experimental
protocols limit the possibilities to interpret this discrepancy
here.
Our data strongly support the involvement of endocyto-
sis as the major route for the internalization of hCT-derived
peptides, Tat(47-57) and penetratin(43-58) into MDCK mono-
layers, in contrast to the direct cytosolic pathway suggested
for other peptides (3,6,10). However, it is important to note
Fig. 3. Determination of LDH release. MDCK cell monolayers were
incubated 30, 60, 120, 180, and 240 min with serum-free medium for
control (white). A, MDCK cells were incubated 30, 60, and 120 min
with 40 M hCT(9-32) (light gray), hCT(18-32) (black), and hCT(21-
32) (dark gray). B, MDCK cells were incubated 60, 120, 180, and 240
min with 10 M Tat(47-57) (black) and penetratin(43-58) (light gray).
The release of LDH is depicted relative to the release amount of
LDH from epithelium exposed to 0.1% Triton X-100. No relevant
toxicity is observed. Mean ± SD (n  4).
Fig. 4. Investigation of hCT receptor on MDCK plasma membrane.
MDCK cells forming monolayers were incubated with different con-
centrations of hCT (), hAmylin (), hCGRP (), and hADM ().
Accumulation of cAMP was measured to investigate the presence of
hCT- or hCT-related peptides receptors on plasma membrane of
MDCK cells. The level of cAMP accumulation remained in the range
of nontreated cells. Therefore, no hCT, hAmylin, hCGRP, and
hADM receptors are expressed on MDCK plasma membrane. For-
skolin () was used as a control to verify the cells capacity to produce
cAMP. All experiments were repeated two times (n 2). The results
were expressed as the ratio of stimulated and untreated controls.
Mean ± SD.
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that the efficiency of peptide uptake was dependent upon
both cell line and peptide sequence. HeLa cells demonstrated
a greater uptake potential than MDCK cells, and Tat(47-57)
was more readily internalized as compared to the hCT-de-
rived peptides. These results indicate that the uptake prob-
ably depends on a cell-specific membrane component or the
specific lipid composition of the membrane. The endocytic
pathway can expose peptide, protein and nucleic acid based-
therapeutics to late endosomal and lysosomal degradation
and, therefore, may represent a problematic pathway for drug
delivery. A recent study showed that when fused to Tat(47-
57), lysosomal -glucuronidase was internalized by endocyto-
sis and the fusion protein’s enzyme activity restored in a
mouse model of -glucuronidase deficiency (37). This dem-
onstrates that a translocated cargo may retain its biological
activity even when transported via an endocytic pathway. Al-
ternatively, endosomal/lysosomal degradation could be con-
sidered as an attractive feature to release the therapeutic
principle from its conjugate. This would necessitate the exis-
tence of a suitable metabolically cleavable spacer between
cargo and peptide.
Recently, artifactual uptake of some CPPs was demon-
strated upon strong and even mild fixation conditions (18,38).
In our study, under both fixed and nonfixed conditions, HeLa
cells showed a similar fluorescence pattern, indicating the ab-
sence of experimental artifacts upon fixation. Supporting this
view is the recent study of Koppelhus et al. demonstrating that
fixation did not negatively effect the vesicular translocation
pattern of PNA conjugated to CPPs (17). Nevertheless, non-
fixed MDCK cells demonstrated a somewhat weaker but oth-
erwise identical, punctuated cytoplasmic fluorescence (not
shown). This result is explained by a higher bleaching of car-
boxyfluorescein in nonfixed cells vs. fixed cells (39). In case of
artifactual redistribution of the peptides after fixation, a pre-
dominantly nuclear localization and the lack of punctuated
cytoplasmic labeling characteristics of endocytic uptake
would be expected, as reported in most published data on
fixed cells (3,10,16).
Interestingly, we found an nonspecific uptake of all the
tested hCT-derived sequences by proliferating MDCK cells,
whereas selected peptides only were internalized by confluent
MDCK. PNA-peptide conjugates also demonstrate faster cel-
lular uptake when using less confluent cells, demonstrating an
influence of the physiologic state of the cells relative to pep-
tide uptake (17). Our findings may point to a more complex
and less general mechanism for the uptake of hCT-derived
peptides in MDCK monolayers as compared to proliferating
cells.
The release of cytoplasmic LDH into the cell culture
supernatant was studied to assess plasma membrane damage
when MDCK cell monolayers were incubated with hCT-de-
rived peptides, Tat(47-57) and penetratin(43-58). No signifi-
cant toxicity induced by the tested peptides was detected.
Koppelhus et al. described a diffuse, strong staining of both
the cytoplasm and the nuclei when the peptides were toxic
(17). The well-defined, punctuated cytoplasmic pattern, de-
scribed in the present work, provides further support in dem-
onstrating that the peptide sequences used in this study did no
exert significant toxicity when incubated with either MDCK
or HeLa.
In conclusion, we propose a new family of modestly cat-
ionic peptides, all derived from human calcitonin, that are
able to translocate MDCK plasma membrane. The translo-
cated hCT peptides demonstrated a sectoral and punctuated
cytoplasmic distribution. Polycationic CPP such as Tat(47-57)
and penetratin(43-58) also showed a punctuated cytoplasmic
distribution in MDCK and HeLa cells. The results obtained in
our study in combination with those of other laboratories lend
support to endocytosis as the common mechanism for peptide
translocation. At this point, it is difficult to outline the struc-
tural requirements for efficient internalization of hCT-de-
rived peptides. Moreover, the observed structure-activity re-
lationship of studied peptides may also relate to variations in
their aggregation potential, as well as differences in their
pathway and rate of metabolism. Work is undergoing to as-
sess the different metabolism kinetics of selected hCT-de-
rived peptides and to optimize the translocating abilities of
hCT-derived peptides. Therefore, further studies need to be
performed to identify an optimized sequence for transloca-
tion and mechanism of action of our CPP.
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